MabThera in combination with chemotherapy is the standard of care in NHL, offering patients with follicular disease prolonged survival and years of life free from relapse and allowing the best chance of a cure in diffuse large B cell lymphoma.
MabThera-based therapy is the standard of care in FL.
MabThera maintenance therapy prolongs response to induction chemotherapy
MabThera approval in relapsed/refractory NHL
MabThera plus CHOP improves overall survival in DLBCL
Download the Brief Prescribing Information for MabThera.
Discover how MabThera effectively eradicates CD20+ cells in lymphoma patients by several distinct mechanisms.
Get regular updates about what's new on MabThera.com, upcoming events and highlights from recent congresses
Find out more about the characteristics of MabThera and how it is used in the treatment of non-Hodgkin's lymphoma.